The effect of GLP-1 receptor agonists on targets for cardiovascular risk reduction

被引：0
|
作者：
Westrick, Christopher [1 ]
Snider, Melissa [1 ]
Arradaza, Nicole [1 ]
Sharma, Kavita [1 ]
机构：
[1] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA
来源：
PHARMACOTHERAPY | 2013年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
27
引用
收藏
页码：E190 / E190
页数：1
相关论文
共 50 条
  • [31] Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence
    Krishnan, Srikanth
    Srivastava, Pratyaksh K.
    Attaluri, Jayram
    Nayeri, Rebecca
    Chatterjee, Dhananjay
    Patel, Jay
    Nsair, Ali
    Budoff, Matthew
    Nayeri, Arash
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2025, 12 (01)
  • [32] GLP-1 receptor agonists in NAFLD
    Petit, J. -M.
    Verges, B.
    DIABETES & METABOLISM, 2017, 43 : 2S28 - 2S33
  • [33] GLP-1 receptor agonists and suicidality
    Ueda, Peter
    Pasternak, Bjorn
    BMJ-BRITISH MEDICAL JOURNAL, 2025, 388
  • [34] Emerging GLP-1 receptor agonists
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    EXPERT OPINION ON EMERGING DRUGS, 2011, 16 (04) : 607 - 618
  • [35] GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
    Ma, Xiaoxuan
    Liu, Zhenghong
    Ilyas, Iqra
    Little, Peter J.
    Kamato, Danielle
    Sahebka, Amirhossein
    Chen, Zhengfang
    Luo, Sihui
    Zheng, Xueying
    Weng, Jianping
    Xu, Suowen
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (08): : 2050 - 2068
  • [36] GLP-1 receptor agonists today
    Marre, Michel
    Penfornis, Alfred
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 (03) : 317 - 327
  • [37] Positioning on GLP-1 receptor agonists
    Gimenez, Sergio
    Piskorz, Daniel
    Martinez Demaria, Diego
    Nanfara, Silvia
    Lorenzatti, Alberto
    Zapata, Gerardo
    Aguinaga Arrascue, Luis
    Perna, Eduardo
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2021, 50 : 4 - 10
  • [38] The Future of the GLP-1 Receptor Agonists
    Hirsch, Irl B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (15): : 1457 - 1458
  • [39] Effect of GLP-1 receptor agonists on prostate cancer risk reduction: a systematic review and meta-analysis
    Sharma, Nikhil
    Khatib, Mahalaqua Nazli
    Balaraman, Ashok Kumar
    Roopashree, R.
    Kaur, Mandeep
    Srivastava, Manish
    Barwal, Amit
    Prasad, G. V. Siva
    Rajput, Pranchal
    Syed, Rukshar
    Sharma, Gajendra
    Kumar, Sunil
    Singh, Mahendra Pratap
    Bushi, Ganesh
    Chilakam, Nagavalli
    Pandey, Sakshi
    Brar, Manvinder
    Mehta, Rachana
    Sah, Sanjit
    Gaidhane, Abhay M.
    Shabil, Muhammed
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, : 1039 - 1049
  • [40] Newly appreciated therapeutic effect of GLP-1 receptor agonists: Reduction in postprandial lipemia
    Bandsma, Robert H. J.
    Lewis, Gary F.
    ATHEROSCLEROSIS, 2010, 212 (01) : 40 - 41
12345